Marrow fat and bone-new perspectives

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 3, 2013, Pages 935-945

  Fazeli, Pouneh K ^a   Horowitz, Mark C ^b   MacDougald, Ormond A ^c   Scheller, Erica L ^c   Rodeheffer, Matthew S ^b   Rosen, Clifford J ^d   Klibanski, Anne ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d Maine Medical Center Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY B CELL FACTOR 1; EPIDERMAL GROWTH FACTOR; HYDROCORTISONE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; MONOUNSATURATED FATTY ACID; NETOGLITAZONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; PLACEBO; POLYUNSATURATED FATTY ACID; PREADIPOCYTE FACTOR 1; ROSIGLITAZONE; SATURATED FATTY ACID; TRANSCRIPTION FACTOR; TRIACYLGLYCEROL; TROGLITAZONE; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; AGING; ANOREXIA NERVOSA; BONE DENSITY; BONE DEVELOPMENT; BONE INTEGRITY; BONE MARROW CELL; BONE MASS; BONE REMODELING; BONE STRENGTH; CALORIC RESTRICTION; CELL DIFFERENTIATION; CELL FUNCTION; CELL POPULATION; CORTICAL BONE; DISEASE ASSOCIATION; DYSLIPIDEMIA; FRACTURE; GROWTH HORMONE DEFICIENCY; HEMATOPOIESIS; HORMONE DETERMINATION; HUMAN; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LEPTIN DEFICIENCY; LIPID COMPOSITION; LIPID STORAGE; LIPOGENESIS; MARROW ADIPOSE TISSUE; MESENCHYMAL STEM CELL; METABOLIC DISORDER; MUSCULOSKELETAL SYSTEM PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OSTEOLYSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; REVIEW; RISK FACTOR; TRABECULAR BONE; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE; ANIMALS; BONE DENSITY; BONE DISEASES, METABOLIC; BONE MARROW; BONE MARROW CELLS; HUMANS;

EID: 84874817050     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-3634     Document Type: Review

References (105)

1. Custer RP. Studies on the structure and function of bone marrow. Part I. J Lab Clin Med. 1932;17:951-960.
2. Kricun ME. Red-yellow marrow conversion: its effect on the location of some solitary bone lesions. Skeletal Radiol. 1985;14:10-19. (Pubitemid 15034403)
3. Custer RP, Ahlfeldt FE. Studies on the structure and function of bone marrow. Part II. J Lab Clin Med. 1932;17:960-962.
4. Burkhardt R, Kettner G, Bohm W, et al. Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: a comparative histomorphometric study. Bone. 1987;8:157-164. (Pubitemid 17111858)
5. Tavassoli M, Houchin DN, Jacobs P. Fatty acid composition of adipose cells in red and yellow marrow: a possible determinant of haematopoietic potential. Scand J Haematol. 1977;18:47-53. (Pubitemid 8021734)
6. Cornish J, MacGibbon A, Lin JM, et al. Modulation of osteoclastogenesis by fatty acids. Endocrinology. 2008;149:5688-5695.
7. Maurin AC, Chavassieux PM, Meunier PJ. Expression of PPARγand β/δ in human primary osteoblastic cells: influence of polyunsaturated fatty acids. Calcif Tissue Int. 2005;76:385-392. (Pubitemid 41557286)
8. Weatherill AR, Lee JY, Zhao L, Lemay DG, Youn HS, Hwang DH. Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4. J Immunol. 2005;174:5390-5397. (Pubitemid 40593178)
9. Griffith JF, Yeung DK, Ahuja AT, et al. A study of bone marrow and subcutaneous fatty acid composition in subjects of varying bone mineral density. Bone. 2009;44:1092-1096.
10. Boyd HM, Peltier LF, Scott JR, Wheeler DH. Fat embolism. II. The chemical composition of fat obtained from human long bones and subcutaneous tissue. Surgery. 1956;40:661-664.
11. Zach E, Shafrir E. Composition of bone marrow adipose tissue in relation to body fat depots in various species. Isr J Med Sci. 1974;10:1541-1550.
12. Trubowitz S, Bathija A. Cell size and plamitate-1-14c turnover of rabbit marrow fat. Blood. 1977;49:599-605. (Pubitemid 8080190)
13. Bathija A, Davis S, Trubowitz S. Bone marrow adipose tissue: response to acute starvation. Am J Hematol. 1979;6:191-198. (Pubitemid 10190131)
14. Tavassoli M. Differential response of bone marrow and extramedullary adipose cells to starvation. Experientia. 1974;30:424-425.
15. Devlin MJ, Cloutier AM, Thomas NA, et al. Caloric restriction leads to highmarrowadiposity and low bone mass in growing mice. J Bone Miner Res. 2010;25:2078-2088.
16. Bredella MA, Fazeli PK, Miller KK, et al. Increased bone marrow fat in anorexia nervosa. J Clin Endocrinol Metab. 2009;94:2129-2136.
17. Ecklund K, Vajapeyam S, Feldman HA, et al. Bone marrow changes in adolescent girls with anorexia nervosa. J Bone Miner Res. 2010;25:298-304.
18. Fazeli PK, Bredella MA, Freedman L, et al. Marrow fat and preadipocyte factor-1 levels decrease with recovery in women with anorexia nervosa. J Bone Miner Res. 2012;27:1864-1871.
19. Thompson NM, Gill DA, Davies R, et al. Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology. 2004;145:234-242. (Pubitemid 38202164)
20. Rodeheffer MS, Birsoy K, Friedman JM. Identification of white adipocyte progenitor cells in vivo. Cell. 2008;135:240-249.
21. Liu LF, Shen WJ, Ueno M, Patel S, Kraemer FB. Characterization of age-related gene expression profiling in bone marrow and epididymal adipocytes. BMC Genomics. 2011;12:212.
22. Moore SG, Dawson KL. Red and yellow marrow in the femur: age-related changes in appearance at MR imaging. Radiology. 1990;175:219-223. (Pubitemid 20108569)
23. Moerman EJ, Teng K, Lipschitz DA, Lecka-Czernik B. Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-γ2 transcription factor and TGF-β/BMP signaling pathways. Aging Cell. 2004;3:379-389. (Pubitemid 40246708)
24. Krings A, Rahman S, Huang S, Lu Y, Czernik PJ, Lecka-Czernik B. Bone marrow fat has brown adipose tissue characteristics, which are attenuated with aging and diabetes. Bone. 2012;50:546-552.
25. Naveiras O, Nardi V, Wenzel PL, Hauschka PV, Fahey F, Daley GQ. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature. 2009;460:259-263.
26. Lin H, Grosschedl R. Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature. 1995;376:263-267.
27. Meunier P, Aaron J, Edouard C, Vignon G. Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. Clin Orthop Relat Res. 1971;80:147-154.
28. Ducy P, Amling M, Takeda S, et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell. 2000;100:197-207. (Pubitemid 30064908)
29. Schellinger D, Lin CS, Lim J, Hatipoglu HG, Pezzullo JC, Singer AJ. Bone marrow fat and bone mineral density on proton MR spectroscopy and dual-energy x-ray absorptiometry: their ratio as a new indicator of bone weakening. AJR Am J Roentgenol. 2004;183:1761-1765. (Pubitemid 44210553)
30. Gimble JM, Robinson CE, Wu X, Kelly KA. The function of adipocytes in the bone marrow stroma: an update. Bone. 1996;19: 421-428.
31. Koh YJ, Kang S, Lee HJ, et al. Bone marrow-derived circulating progenitor cells fail to transdifferentiate into adipocytes in adult adipose tissues in mice. J Clin Invest. 2007;117:3684-3695. (Pubitemid 350224080)
32. Fretz JA, Nelson T, Xi Y, Adams DJ, Rosen CJ, Horowitz MC. Altered metabolism and lipodystrophy in the early B-cell factor 1-deficient mouse. Endocrinology. 2010;151:1611-1621.
33. Kveiborg M, Sabatakos G, Chiusaroli R, et al. δ-FosB induces osteosclerosis and decreases adipogenesis by two independent cellautonomous mechanisms. Mol Cell Biol. 2004;24:2820-2830. (Pubitemid 38381272)
34. Schick F, Einsele H, Bongers H, et al. Leukemic red bone marrow changes assessed by magnetic resonance imaging and localized 1H spectroscopy. Ann Hematol. 1993;66:3-13. (Pubitemid 23066931)
35. Schellinger D, Lin CS, Fertikh D, et al. Normal lumbar vertebrae: anatomic, age, and sex variance in subjects at proton MR spectroscopy-initial experience. Radiology. 2000;215:910-916. (Pubitemid 30346040)
36. Shen W, Chen J, Punyanitya M, Shapses S, Heshka S, Heymsfield SB. MRI-measured bone marrow adipose tissue is inversely related to DXA-measured bone mineral in Caucasian women. Osteoporos Int. 2007;18:641-647. (Pubitemid 46525539)
37. Shen W, Scherzer R, Gantz M, et al. Relationship between MRI measured bone marrow adipose tissue and hip and spine bone mineral density in African-American and Caucasian participants: the CARDIA study. J Clin Endocrinol Metab. 2012;97:1337-1346.
38. Di Iorgi N, Rosol M, Mittelman SD, Gilsanz V. Reciprocal relation between marrow adiposity and the amount of bone in the axial and appendicular skeleton of young adults. J Clin Endocrinol Metab. 2008;93:2281-2286. (Pubitemid 351831548)
39. Justesen J, Stenderup K, Ebbesen EN, Mosekilde L, Steiniche T, Kassem M. Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology. 2001;2:165-171. (Pubitemid 32851325)
40. Schellinger D, Lin CS, Hatipoglu HG, Fertikh D. Potential value of vertebral proton MR spectroscopy in determining bone weakness. AJNR Am J Neuroradiol. 2001;22:1620-1627. (Pubitemid 32862282)
41. Russell M, Mendes N, Miller KK, et al. Visceral fat is a negative predictor of bone density measures in obese adolescent girls. J Clin Endocrinol Metab. 2010;95:1247-1255.
42. Bredella MA, Torriani M, Ghomi RH, et al. Determinants of bone mineral density in obese premenopausal women. Bone. 2011;48: 748-754.
43. Katzmarzyk PT, Barreira TV, Harrington DM, Staiano AE, Heymsfield SB, Gimble JM. Relationship between abdominal fat and bone mineral density in white and African American adults. Bone. 2012;50:576-579.
44. Campos RM, Lazaretti-Castro M, Mello MT, et al. Influence of visceral and subcutaneous fat in bone mineral density of obese adolescents. Arq Bras Endocrinol Metabol. 2012;56:12-18.
45. Wren TA, Chung SA, Dorey FJ, Bluml S, Adams GB, Gilsanz V. Bone marrow fat is inversely related to cortical bone in young and old subjects. J Clin Endocrinol Metab. 2011;96:782-786.
46. Post S, Abdallah BM, Bentzon JF, Kassem M. Demonstration of the presence of independent pre-osteoblastic and pre-adipocytic cell populations in bone marrow-derived mesenchymal stem cells. Bone. 2008;43:32-39.
47. Benvenuti S, Cellai I, Luciani P, et al. Androgens and estrogens prevent rosiglitazone-induced adipogenesis in human mesenchymal stem cells. J Endocrinol Invest. 2012;35:365-371.
48. Riggs BL, Khosla S, Melton LJ III. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev. 2002;23:279-302. (Pubitemid 34651948)
49. Syed FA, Oursler MJ, Hefferanm TE, Peterson JM, Riggs BL, Khosla S. Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women. Osteoporos Int. 2008;19: 1323-1330.
50. Wehrli FW, Hopkins JA, Hwang SN, Song HK, Snyder PJ, Haddad JG. Cross-sectional study of osteopenia with quantitative MR imaging and bone densitometry. Radiology. 2000;217:527-538.
51. Meyer U, Romann M, Zahner L, et al. Effect of a general schoolbased physical activity intervention on bone mineral content and density: a cluster-randomized controlled trial. Bone. 2011;48:792-797.
52. Casazza K, Hanks LJ, Hidalgo B, Hu HH, Affuso O. Short-term physical activity intervention decreases femoral bone marrow adipose tissue in young children: a pilot study. Bone. 2012;50:23-27.
53. Bredella MA, Torriani M, Ghomi RH, et al. Vertebral bone marrow fat is positively associated with visceral fat and inversely associated with IGF-1 in obese women. Obesity (Silver Spring). 2011;19:49-53.
54. Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis. Osteoporos Int. 2007;18:427-444. (Pubitemid 46354916)
55. McCabe LR. Understanding the pathology and mechanisms of type I diabetic bone loss. J Cell Biochem. 2007;102:1343-1357. (Pubitemid 350223938)
56. Botolin S, Faugere MC, Malluche H, Orth M, Meyer R, McCabe LR. Increased bone adiposity and peroxisomal proliferator-activated receptor-γ2 expression in type I diabetic mice. Endocrinology. 2005;146:3622-3631. (Pubitemid 41058134)
57. Botolin S, McCabe LR. Bone loss and increased bone adiposity in spontaneous and pharmacologically induced diabetic mice. Endocrinology. 2007;148:198-205. (Pubitemid 46021451)
58. Slade JM, Coe LM, Meyer RA, McCabe LR. Human bone marrow adiposity is linked with serum lipid levels not T1-diabetes. J Diabetes Complications. 2012;26:1-9.
59. Baum T, Yap SP, Karampinos DC, et al. Does vertebral bone marrow fat content correlate with abdominal adipose tissue, lumbar spine bone mineral density, and blood biomarkers in women with type 2 diabetes mellitus? J Magn Reson Imaging. 2012;35:117-124.
60. Ackert-Bicknell CL, Shockley KR, Horton LG, Lecka-Czernik B, Churchill GA, Rosen CJ. Strain-specific effects of rosiglitazone on bone mass, body composition, and serum insulin-like growth factor-I. Endocrinology. 2009;150:1330-1340.
61. Tornvig L, Mosekilde LI, Justesen J, Falk E, Kassem M. Troglitazone treatment increases bone marrow adipose tissue volume but does not affect trabecular bone volume in mice. Calcif Tissue Int. 2001;69:46-50. (Pubitemid 32702265)
62. Lazarenko OP, Rzonca SO, Suva LJ, Lecka-Czernik B. Netoglitazone is aPPAR-γ ligand with selective effects on bone and fat. Bone. 2006;38:74-84. (Pubitemid 43006077)
63. Harslof T, Wamberg L, Moller L, et al. Rosiglitazone decreases bone mass and bone marrow fat. J Clin Endocrinol Metab. 2011;96:1541-1548.
64. Grey A, Beckley V, Doyle A, et al. Pioglitazone increases bone marrow fat in type 2 diabetes: results from a randomized controlled trial. Eur J Endocrinol. 2012;166:1087-1091.
65. Elefteriou F, Ahn JD, Takeda S, et al. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature. 2005;434:514-520. (Pubitemid 40477060)
66. Takeda S, Elefteriou F, Levasseur R, et al. Leptin regulates bone formation via the sympathetic nervous system. Cell. 2002;111: 305-317. (Pubitemid 35345151)
67. Ingalls AM, Dickie MM, Snell GD. Obese, a new mutation in the house mouse. J Hered. 1950;41:317-318.
68. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425-432. (Pubitemid 24365442)
69. Charlton HM. Mouse mutants as models in endocrine research.Q J Exp Physiol. 1984;69:655-676. (Pubitemid 15213610)
70. Hamrick MW. Leptin, bone mass, and the thrifty phenotype. J Bone Miner Res. 2004;19:1607-1611. (Pubitemid 41094322)
71. Bartell SM, Rayalam S, Ambati S, et al. Central (ICV) leptin injection increases bone formation, bone mineral density, muscle mass, serum IGF-1, and the expression of osteogenic genes in leptin-deficient ob/ob mice. J Bone Miner Res. 2011;26:1710-1720.
72. Gryglewski RJ. Prostacyclin among prostanoids. Pharmacol Rep. 2008;60:3-11. (Pubitemid 351586537)
73. Iwaniec UT, Boghossian S, Trevisiol CH, Wronski TJ, Turner RT, Kalra SP. Hypothalamic leptin gene therapy prevents weight gain without long-term detrimental effects on bone in growing and skeletally mature female rats. J Bone Miner Res. 2011;26:1506-1516.
74. Williams GA, Callon KE, Watson M, et al. Skeletal phenotype of the leptin receptor-deficient db/db mouse. J Bone Miner Res. 2011;26:1698-1709.
75. Scheller EL, Song J, Dishowitz MI, Soki FN, Hankenson KD, Krebsbach PH. Leptin functions peripherally to regulate differentiation of mesenchymal progenitor cells. Stem Cells. 2010;28: 1071-1080.
76. DeMambro VE, Kawai M, Clemens TL, et al. Anovel spontaneous mutation of Irs1 in mice results in hyperinsulinemia, reduced growth, low bone mass and impaired adipogenesis. J Endocrinol. 2010;204:241-253.
77. Martin LM, McCabe LR. Type I diabetic bone phenotype is location but not gender dependent. Histochem Cell Biol. 2007;128: 125-133. (Pubitemid 47197932)
78. Charlton HM, Clark RG, Robinson IC, et al. Growth hormonedeficient dwarfism in the rat: a new mutation. J Endocrinol. 1988;119:51-58.
79. Gevers EF, Loveridge N, Robinson IC. Bone marrow adipocytes: a neglected target tissue for growth hormone. Endocrinology. 2002;143:4065-4073. (Pubitemid 35244386)
80. Menagh PJ, Turner RT, Jump DB, et al. Growth hormone regulates the balance between bone formation and bone marrow adiposity. J Bone Miner Res. 2010;25:757-768.
81. Di Iorgi N, Mittelman SD, Gilsanz V. Differential effect of marrow adiposity and visceral and subcutaneous fat on cardiovascular risk in young, healthy adults. Int J Obes (Lond). 2008;32:1854-1860.
82. Geiser F, Murtz P, Lutterbey G, et al. Magnetic resonance spectroscopic and relaxometric determination of bone marrow changes in anorexia nervosa. Psychosom Med. 2001;63:631-637. (Pubitemid 32695144)
83. Lambert M, Hubert C, Depresseux G, et al. Hematological changes in anorexia nervosa are correlated with total body fat mass depletion. Int J Eat Disord. 1997;21:329-334. (Pubitemid 27184001)
84. Abella E, Feliu E, Granada I, et al. Bone marrow changes in anorexia nervosa are correlated with the amount of weight loss and not with other clinical findings. Am J Clin Pathol. 2002;118:582-588. (Pubitemid 44698515)
85. Fazeli PK, Bredella MA, Misra M, et al. Preadipocyte factor-1 is associated with marrow adiposity and bone mineral density in women with anorexia nervosa. J Clin Endocrinol Metab. 2010;95:407-413.
86. Lawson EA, Misra M, Meenaghan E, et al. Adrenal glucocorticoid and androgen precursor dissociation in anorexia nervosa. J Clin Endocrinol Metab. 2009;94:1367-1371.
87. Lawson EA, Donoho D, Miller KK, et al. Hypercortisolemia is associated with severity of bone loss and depression in hypothalamic amenorrhea and anorexia nervosa. J Clin Endocrinol Metab. 2009;94:4710-4716.
88. Greenberger JS. Corticosteroid-dependent differentiation of human marrow preadipocytes in vitro. In Vitro. 1979;15:823-828. (Pubitemid 10170789)
89. Pongubala JM, Northrup DL, Lancki DW, et al. Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5. Nat Immunol. 2008;9: 203-215.
90. Liberg D, Sigvardsson M, Akerblad P. The EBF/Olf/Collier family of transcription factors: regulators of differentiation in cells originating from all three embryonal germ layers. Mol Cell Biol. 2002;22:8389-8397. (Pubitemid 35397155)
91. Hesslein DG, Fretz JA, Xi Y, et al. Ebf1-dependent control of the osteoblast and adipocyte lineages. Bone. 2009;44:537-546.
92. Akerblad P, Lind U, Liberg D, Bamberg K, Sigvardsson M. Early B-cell factor (O/E-1) is a promoter of adipogenesis and involved in control of genes important for terminal adipocyte differentiation. Mol Cell Biol. 2002;22:8015-8025. (Pubitemid 35217309)
93. Jimenez MA, Akerblad P, Sigvardsson M, Rosen ED. Critical role for Ebf1 and Ebf2 in the adipogenic transcriptional cascade. Mol Cell Biol. 2007;27:743-757. (Pubitemid 46080139)
94. Akerblad P, Mansson R, Lagergren A, et al. Gene expression analysis suggests that EBF-1 and PPARγ2 induce adipogenesis of NIH-3T3 cells with similar efficiency and kinetics. Physiol Genomics. 2005;23:206-216. (Pubitemid 44437979)
95. Gimble JM, Morgan C, Kelly K, et al. Bone morphogenetic proteins inhibit adipocyte differentiation by bone marrow stromal cells. J Cell Biochem. 1995;58:393-402.
96. Vost A. Osteoporosis: a necropsy study of vertebrae and iliac crests. Am J Pathol. 1963;43:143-151.
97. Hartsock RJ, Smith EB, Petty CS. Normal variations with aging of the amount of hematopoietic tissue in bone marrow from the anterior iliac crest. A study made from 177 cases of sudden death examined by necropsy. Am J Clin Pathol. 1965;43:326-331.
98. Festa E, Fretz J, Berry R, et al. Adipocyte lineage cells contribute to the skin stem cell niche to drive hair cycling. Cell. 2011;146:761-771.
99. Lecka-Czernik B. Marrow fat metabolism is linked to the systemic energy metabolism. Bone. 2012;50:534-539.
100. Bennett CN, Ouyang H, Ma YL, et al. Wnt10b increases postnatal bone formation by enhancing osteoblast differentiation. J Bone Miner Res. 2007;22:1924-1932. (Pubitemid 351229309)
101. DeMambro VE, Clemmons DR, Horton LG, et al. Gender-specific changes in bone turnover and skeletal architecture in igfbp-2-null mice. Endocrinology. 2008;149:2051-2061. (Pubitemid 351574504)
102. Babij P, Zhao W, Small C, et al. High bone mass in mice expressing a mutant LRP5 gene. J Bone Miner Res. 2003;18:960-974. (Pubitemid 37294932)
103. Kato M, Patel MS, Levasseur R, et al. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol. 2002;157:303-314. (Pubitemid 34839826)
104. Botolin S, McCabe LR. Inhibition of PPARγ prevents type I diabetic bone marrow adiposity but not bone loss. J Cell Physiol. 2006;209:967-976. (Pubitemid 44665719)
105. Hui SK, Sharkey L, Kidder LS, et al. The influence of therapeutic radiation on the patterns of bone marrow in ovary-intact and ovariectomized mice. PLoS One. 2012;7:e42668.